Mode
Text Size
Log in / Sign up
N/A Completed N=30 Basic Science

Effectiveness of a 6-week Hippotherapy Program in Children With Autism Spectrum Disorder

Source: ClinicalTrials.gov NCT04772898 ↗
Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Mar 2024
Primary outcomePrimary: Social Responsiveness Scale (SRS) — 16.5; 89.06; 14.5; 79.8 Points

Summary

The prevalence of autism spectrum disorders (ASD) has increased dramatically in the last decade. The increasing occurrence of ASD creates an imperative need to test the effectiveness and efficacy mechanisms of appropriate interventions. Hippotherapy (HPOT) is a treatment option that has been show beneficial for children with ASD as well as other children with developmental disorders. The current projects focuses on understanding the mechanisms of HPOT efficacy and evaluating a short-term HPOT program for children with ASD.

Outcome Measures

OutcomeResultp-value
PRIMARY
Social Responsiveness Scale (SRS)
16.5; 89.06; 14.5; 79.8
PRIMARY
Postural Control
0.525; 0.48; 0.53; 0.57
PRIMARY
Cross Sample Entropy Between the Heart Rate Sensors of the Horse and Rider
0.685; 0.512; 0.644; 0.578; 0.681; 0.564
SECONDARY
Correlation Between Horse Temperament and Therapeutic Outcomes
SECONDARY
Aberrant Behavior Checklist

Eligibility Criteria

For the children with Autism Spectrum Disorders:

Inclusion Criteria

  • diagnosis of ASD based upon the Autism Diagnostic Observation Schedule and parent interview,
  • medical approval for participation in the HPOT activity,
  • no other medical or psychiatric diagnoses besides ASD
  • tolerate helmet on head and attachments of the movement and heart rate sensors.

The inclusion criteria for the TD children will be:

  • no diagnosis or family history of ASD
  • no other neurodevelopmental or musculoskeletal disorder
  • tolerate helmet on head and attachments of the movement and heart rate sensors.
  • medical approval for participation in the HPOT activity,

Exclusion Criteria

  • under 5 years of age or over 10 years of age
  • has a serious comorbid medical diagnosis
  • major vision or hearing impairments
  • severe behavioral problems
  • an orthopedic or genetic diagnosis
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04772898). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search